Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Phase 3 successful for Amgen's adalimumab biosimilar
Seeking Alpha
Wednesday, October 8, 2014 - 10:09am
tags:
Amgen, adalimumab, biosimilars, Humira, ABP 501
Chimerix drug used for Ebola shows promise in respiratory cases
Reuters
Wednesday, October 8, 2014 - 10:04am
tags:
Chimerix, ebola virus, adenovirus, Brincidofovir
Safety advocates seek stronger warnings on Chantix
Yahoo/AP
Wednesday, October 8, 2014 - 9:52am
tags:
Chantix, Pfizer, smoking cessation, FDA
Is The Pharma Industry Overvalued?
Bidness Etc.
Wednesday, October 8, 2014 - 7:45am
tags:
pharma stocks
Novartis says 3 executives to leave after GSK, Lilly deals
Yahoo/Reuters
Wednesday, October 8, 2014 - 7:31am
tags:
Novartis, GSK, Eli Lilly
[video]Actavis plans new Allergan approach: Report
CNBC
Tuesday, October 7, 2014 - 4:53pm
tags:
Actavis, Allergan, M&A, Valeant Pharmaceuticals
Salix: The Field of Potential Buyers is Vast, Analyst Says
WSJ Online
Tuesday, October 7, 2014 - 4:52pm
tags:
Salix, M&A, Actavis, Allergan, AstraZeneca, Takeda
The Battle For Lung Cancer Drugs Continues
Bidness Etc.
Tuesday, October 7, 2014 - 1:45pm
tags:
lung cancer, AstraZeneca, Clovis Oncology, AZD9291, CO-1686
Gilead Sciences: Here Comes the Competition
Barron's
Tuesday, October 7, 2014 - 1:21pm
tags:
Gilead Sciences, hepatitis C, Sovaldi, Merck, AbbVie, Idenix, Bristol-Myers Squibb, Achillion
$1.1 billion in drug, device payments to doctors not included in new federal database
Mass Device
Tuesday, October 7, 2014 - 12:24pm
tags:
physicial payments, Physician Payment Sunshine Act, devices
Balking at marketing slapdown, Galderma declares itself pharma non grata
Fierce Pharma Marketing
Tuesday, October 7, 2014 - 11:55am
tags:
Galderma, PCMPA
Report: Financial conflicts sway studies of flu fighters Tamiflu and Relenza
Fierce Pharma
Tuesday, October 7, 2014 - 11:50am
tags:
influenza, Tamiflu, RELENZA, GSK, Roche
Positive PhIII PONV study brings little Acacia to a crossroads
Fierce Biotech
Tuesday, October 7, 2014 - 11:48am
tags:
Acacia Pharma, PONV
Zoetis Will Benefit from Industry Trends
Yahoo/Gurufocus
Tuesday, October 7, 2014 - 11:26am
tags:
Zoetis, animal health
Hyperion, Clal Biotech resolve dispute over diabetes drug
Yahoo/Reuters
Tuesday, October 7, 2014 - 11:25am
tags:
Hyperion, Clal Biotech, diabetes, DiaPep277
Novartis takes three licenses to ImmunoGen drug targets
Seeking Alpha
Tuesday, October 7, 2014 - 11:19am
tags:
Novartis, Immunogen
Bristol-Myers Squibb pulls FDA filing for asunaprevir, citing rapidly evolving hepatitis C field
First Word Pharma
Tuesday, October 7, 2014 - 8:48am
tags:
Bristol-Myers Squibb, asunaprevir, hepatitis C
Top execs bicker over Sanofi's plan to unload $8B portfolio of old drugs
Fierce Pharma
Tuesday, October 7, 2014 - 8:34am
tags:
Sanofi
Sovaldi may be cost-effective, but the U.K. can't afford it, documents say
Fierce Pharma
Tuesday, October 7, 2014 - 8:09am
tags:
Sovaldi, UK, drug pricing, Gilead Sciences, hepatitis C
Medtronic Enters Market For Smartphone-enabled Glucose Monitoring Systems
Bidness Etc.
Tuesday, October 7, 2014 - 7:47am
tags:
Medtronic, diabetes, devices, blood glucose monitoring, Medtronic Guardian Mobile, smartphones

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.